Literature DB >> 27744538

Disclosing Huntington's Genetic Testing Results in the Context of Intellectual Disability and Guardianship: Using the Family Illness Narrative to Guide the Flow of Information.

Mark B Warren1, Kathryn M Schak2.   

Abstract

A diagnosis of Huntington's disease has broad social, vocational, reproductive and psychological implications. The ability to accurately diagnose the illness via genetic testing is not new. However, given a persistent lack of robustly effective interventions, it remains an area of ethical concern. The difficulty is compounded in cases of intellectual disability. This paper presents a case of genetic testing for Huntington's disease conducted on a patient with intellectual disability with guardian consent, but without the patient's direct knowledge and how the family illness narrative and psychiatric care were employed in the eventual disclosure of the patient's diagnosis and subsequent management.

Entities:  

Keywords:  Family illness narrative; Guardianship; Huntington’s disease; Intellectual disability; Predictive genetic testing

Mesh:

Year:  2016        PMID: 27744538     DOI: 10.1007/s10897-016-0007-1

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  11 in total

Review 1.  Huntington's disease.

Authors:  Francis O Walker
Journal:  Lancet       Date:  2007-01-20       Impact factor: 79.321

2.  Family illness narratives of inherited cancer risk: continuity and transformation.

Authors:  Allison Werner-Lin; Daniel S Gardner
Journal:  Fam Syst Health       Date:  2009-09       Impact factor: 1.950

Review 3.  Huntington disease: natural history, biomarkers and prospects for therapeutics.

Authors:  Christopher A Ross; Elizabeth H Aylward; Edward J Wild; Douglas R Langbehn; Jeffrey D Long; John H Warner; Rachael I Scahill; Blair R Leavitt; Julie C Stout; Jane S Paulsen; Ralf Reilmann; Paul G Unschuld; Alice Wexler; Russell L Margolis; Sarah J Tabrizi
Journal:  Nat Rev Neurol       Date:  2014-03-11       Impact factor: 42.937

4.  A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.

Authors: 
Journal:  Cell       Date:  1993-03-26       Impact factor: 41.582

5.  Ethical and policy issues in genetic testing and screening of children.

Authors: 
Journal:  Pediatrics       Date:  2013-02-21       Impact factor: 7.124

Review 6.  Current therapeutic options for Huntington's disease: good clinical practice versus evidence-based approaches?

Authors:  Annie Killoran; Kevin M Biglan
Journal:  Mov Disord       Date:  2014-08-27       Impact factor: 10.338

7.  'You don't make genetic test decisions from one day to the next'--using time to preserve moral space.

Authors:  Jackie Leach Scully; Rouven Porz; Christoph Rehmann-Sutter
Journal:  Bioethics       Date:  2007-05       Impact factor: 1.898

8.  Technical report: Ethical and policy issues in genetic testing and screening of children.

Authors:  Lainie Friedman Ross; Laine Friedman Ross; Howard M Saal; Karen L David; Rebecca R Anderson
Journal:  Genet Med       Date:  2013-02-21       Impact factor: 8.822

9.  The Effects of Pharmacological Inhibition of Histone Deacetylase 3 (HDAC3) in Huntington's Disease Mice.

Authors:  Haiqun Jia; Ying Wang; Charles D Morris; Vincent Jacques; Joel M Gottesfeld; James R Rusche; Elizabeth A Thomas
Journal:  PLoS One       Date:  2016-03-31       Impact factor: 3.240

10.  Laquinimod dampens hyperactive cytokine production in Huntington's disease patient myeloid cells.

Authors:  Lucianne Dobson; Ulrike Träger; Ruth Farmer; Liat Hayardeny; Pippa Loupe; Michael R Hayden; Sarah J Tabrizi
Journal:  J Neurochem       Date:  2016-04-05       Impact factor: 5.372

View more
  2 in total

1.  Special Issue Introduction: Dealing with Psychological and Social Complexity in Genetic Counseling.

Authors:  Luba Djurdjinovic; June A Peters
Journal:  J Genet Couns       Date:  2017-03-07       Impact factor: 2.537

2.  Ethical concerns relating to genetic risk scores for suicide.

Authors:  Anna Docherty; Brent Kious; Teneille Brown; Leslie Francis; Louisa Stark; Brooks Keeshin; Jeffrey Botkin; Emily DiBlasi; Doug Gray; Hilary Coon
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2021-09-01       Impact factor: 3.568

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.